Ground-breaking CAR-T therapy to treat aggressive form of blood cancer approved
More than 400 people set to benefit after NICE recommends first personalised immunotherapy for lymphoma.
More than 400 people set to benefit after NICE recommends first personalised immunotherapy for lymphoma.
New Chief Medical Officer, Chief People Officer and Director of Implementation and Partnerships appointed by NICE.
Adults with depression who want to stop taking antidepressants should have the dose of their medication reduced in stages to reduce the likelihood and severity of withdrawal symptoms, NICE has said.
New evidence on the safety of statins means more people could benefit from them, new NICE draft guidance says.
Around 105,000 people with type 1 diabetes could benefit from NICE’s draft recommendation
Founding chairman led NICE from 1999 to 2013, through its early years to its current position as a world leader in health and social care guidance and medicine evaluation.
Page 25 of 39